Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 60 | Mind Blowing Facts

Egypt Receives 1.5 Million COVID Vaccine Doses from US

Egypt has received 1.5 million doses of Pfizer’s coronavirus vaccine donated by the US government. Acting Health Minister Khaled Abdel Ghaffar said Egypt received 1,501,110 Pfizer COVID-19 vaccine doses gifted by the US and delivered through the COVAX initiative and in cooperation with the Vaccine Alliance (GAVI). The new batch…

Asharq Al-Awsat

What's Going On With Pfizer Stock Today?

Pfizer Inc (NYSE: PFE) shares are trading higher Thursday. The company announced the acquisition of ReViral for a total consideration of up to $525 million.

Benzinga

What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?

Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer Beefs Up Its RSV Antiviral Portfolio With $525M ReViral Acquisition

Pfizer Inc (NYSE: PFE)

Benzinga

The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

The high-stakes push to get COVID vaccines to young children

The Omicron variant and and anti-vaccine backlash are complicating the effort.

Axios

Second COVID booster shot extends protection for just a few weeks, study shows

A fourth shot of the Pfizer COVID-19 vaccine increased protection against viral infection for only four to seven weeks, according to a massive study published Tuesday.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Sadiq Khan calls on leading vaccine manufacturers to share Covid jab blueprints with world

Exclusive: Sadiq Khan, alongside mayors of New York and Johannesburg, urged companies ‘to do all you can’ to promote vaccine equity and ‘help stop the unnecessary loss of life’

The Independent UK

Pfizer/BioNTech's Second COVID-19 Vaccine Booster Provides Short-Lived Protection In Elderly, Israel Study Shows

An Israel-based study has found that a fourth dose of the Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) vaccine lowered rates of COVID-19 infection among the elderly.

Benzinga

No Evidence to Support Widespread Use of Fourth COVID Shot, Say EU Agencies

EU health agencies said on Wednesday there was no evidence to support the use of a fourth dose of COVID-19 vaccines developed by Pfizer and Moderna in the general population, but they recommend a second booster for people aged 80 and above. There is no clear evidence in the European…

Asharq Al-Awsat

New Covid antibody rates, how vaccine works, immunity – and how long you’re protected for

As Covid infection rates remain high across the country and people continue to lose their lives, we take a look at how the vaccines work, antibody levels across the UK and how quickly protection drops off

Daily Mirror

Second booster shields elderly from COVID but protection wanes quickly - study

A fourth dose of the Pfizer/BioNTech vaccine lowered rates of COVID-19 among the elderly but the protection against infection appeared short-lived, a large study in Israel has found.

Reuters

Future of COVID boosters comes down to crucial meeting of FDA Advisers

An all-star panel of COVID-19 experts will convene this week to hash out how and when vaccines should be updated to address future variants as the virus continues to rapidly mutate.

Tribune News Service

mRNA Vaccine Maker CEOs Pocketed $100M In Pandemic Pay: FT

The CEOs of Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) have sha

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

CDC Says Heart Inflammation Risk Higher After COVID-19 Infection Than mRNA Vaccines: CNBC

According to a study published by the Centers for Disease Control and Prevention, myocarditis, pericarditis, and multisystem inflammatory syndrome w

Benzinga

Looking At Pfizer's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 10 strange trades.

Tribune News Service

‘The danger is still there’: As omicron lurks, native Americans are wary of boosters

When COVID-19 vaccines first became available, Native Americans acted swiftly and with determination to get their shots — as though they had everything to lose.

Tribune News Service

China promotes traditional cures as Pfizer pill alternatives

As Hong Kong’s outbreak became the deadliest in the world, among the aid Beijing sent to the financial hub were 1 million packets of honeysuckle, rhubarb root, sweet wormwood herb and other natural ingredients, all mixed according to principles of traditional Chinese medicine.

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Anti-vax: COVID vax causes AIDS

Right-wing anti-vax activist Dr. Sherri Tenpenny was ridiculed for her statements

The Guardian - UK

Covid vaccine slots open for children aged five to 11 in England

Parents and other carers now able to book lower-dose appointments for Monday onwards

The Guardian - UK

The Guide #28: The winners and losers of ‘slapgate’

In this week’s newsletter: after days of bad tweets and red carpet reactions, here’s the last word on the biggest Oscars moment of the decade

Benzinga

Pfizer/BioNTech's COVID- Vaccine Cuts Hospitalization Risk In Kids Aged 5-11 Years: Reuters

According to a US-based study, children ages 5 to 11 who received the Pfizer Inc (NYSE:PFE) / BioNTech SE's (NASDAQ:BNTX) COVID-19 vaccine were 68% less likely to be hospitalized during the omicron wave than unvaccinated children. Adolescents aged 12-18 who received two shots of the vaccine were around 40% less likely to be hospitalized with the…

Caixin Global

Opinion: In Crisis Mode, Shanghai Should Stick to Zero-Covid Approach

A UCLA professor’s long-term coexistence plan won’t help and could hinder Shanghai’s response to the current crisis, a Zhejiang University professor argues

Reuters

Governments want COVID vaccine developers to aim higher in hunt for better shots

As governments prepare to live with COVID-19, some are questioning how much to rely on drugmakers to adapt vaccines to ward off future virus variants amid signs of tension between companies and regulators over the best approach, according to several sources familiar with the matter.

Axios

Biden's looming prescription drug pricing dilemma

Pressure is increasing on the administration to go after drug patents.

1 … 59 60 61 62

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.